Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies

Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies

Patients with high-risk non-metastatic breast cancer are recommended for chemotherapy, preferably in the neoadjuvant setting. Beyond advantages such as a better operability and an improved assessment of individual prognosis, the preoperative administration of systemic treatment offers the unique pos...

Full description

Bibliographic Details
Main Authors: Natalia Krawczyk, Tanja Fehm, Eugen Ruckhaeberle, Laura Brus, Valeria Kopperschmidt, Achim Rody, Lars Hanker, Maggie Banys-Paluchowski
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
breast cancer
post-neoadjuvant therapy
HER2 positive
therapy response
survival
Online Access:https://www.mdpi.com/2072-6694/14/12/3002

Internet

https://www.mdpi.com/2072-6694/14/12/3002

Similar Items